FDA panel and the politics of peptide access
Posted by kevin291 in Safety & Side Effects - 3 points, 0 comments.
Ars Technica is reporting on how RFK Jr. is trying to push the FDA to reverse its stance on several popular peptides by stacking an advisory panel with his own allies. It looks like a massive political fight over whether these compounds should be easier to get despite a lack of formal safety data.
Fwiw, the clash between the scientists and the promoters is expected. The FDA is always slow, but the lack of data is a real problem for those of us who actually track our numbers. I dont trust the gray market blindly. When I track my HRV and bloodwork, I want to know exactly what is in the vial. Just because a few influencers say something is lekker doesnt mean it is safe for everyone.
Do you think deregulation would actually improve quality control, or would it just lead to more garbage products hitting the market? I suspect the latter. It seems like a recipe for more side effects because there is no oversight on purity.
Community discussion - research and educational context only. Not medical advice.